Authors: MIRELESVIEYRA MP FEREGRINOGOYOS M TORRASGINER V HIGUERARAMIREZ F ALVARADODIEZ R GOMEZCARO WH

Citation: Mp. Mirelesvieyra et al., LONG-TIME RETROSPECTIVE STUDY OF COMPARATION OF MONOTHERAPY WITH AZT IN COMPARATION WITH COMBINATION AZT PLUS DOC, AZT PLUS DDI AND AZT PLUS 3TC, AIDS, 10, 1996, pp. 31-31

Authors: GOMEZCARO WH FEREGRINOGOYOS M ALVARADODIEZ R MIRELESVIEYRA MP TORRASGINER V

Citation: Wh. Gomezcaro et al., SAQUINAVIR PLUS 3TC PLUS AZT OR DDC PLUS AZT IN ADVANCED HIV AIDS PATIENTS/, AIDS, 10, 1996, pp. 33-33

Authors: FEREGRINOGOYOS M GOMEZCARO WH ALVARADODIEZ R YIEYRA MPM TORRASGINER V

Citation: M. Feregrinogoyos et al., THALIDOMIDE AND KETOPROFEN REDUCE THE INCIDENCE OF ADVERSE EVENTS OF INTERLEUKIN-2 AND ENHANCE THE ANTIVIRAL ACTIVITY OF CD8 IN HIV AIDS PATIENTS/, AIDS, 10, 1996, pp. 60-60

Authors: ALVARADODIEZ R FEREGRINOGOYOS M MIRELESVIEYRA MP GOMEZCARO WH

Citation: R. Alvaradodiez et al., PROPHYLACTIC USE OF FILGASTRIM REDUCE THE RISK OF NEUTROPENNIA IN GANCICLOVIR TREATMENT, AIDS, 10, 1996, pp. 92-92

Authors: FEREGRINOGOYOS M ROSSIGNOL JF HIGUERARAMIREZ F GOMEZCARO WH CRUZ AG HIDALGO H

Citation: M. Feregrinogoyos et al., CLINICAL-STUDY OF NITAZOXAMIDE IN THE THERAPY OF CRYPTOSPORIDIUM-PARVUM IN PATIENTS WITH AIDS - PRELIMINARY REPORTS TRIALS - CL NTZ-OO1, 002,003-MEX 95-96/, AIDS, 10, 1996, pp. 93-93